Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

Articles published in
Radiother Oncol
    June 2026
  1. BURLILE JF, Harmsen WS, Suddendorf SD, Frechette KM, et al
    Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.
    Radiother Oncol. 2026;219:111515.
    >> Share

    April 2026
  2. LEVIS M, Solidoro P, Giglioli FR, Gallio E, et al
    Continuous positive airway pressure as an alternative to deep-inspiration breath holding for mediastinal lymphoma radiotherapy.
    Radiother Oncol. 2026;220:111539.
    >> Share

    February 2026
  3. ALI E, Simontacchi G, Levis M, Iori F, et al
    Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective Study.
    Radiother Oncol. 2026;215:111327.
    >> Share

  4. HIGGINS MJ, Johnstone P, Prince HM, Lade S, et al
    Radiotherapy dose-response of mycosis fungoides with large cell transformation.
    Radiother Oncol. 2026;215:111292.
    >> Share

    January 2026
  5. JOHNSTONE P, Bressel M, Seymour JF, Juneja S, et al
    Secondary outcomes of the TROG 99.03 randomized trial of systemic therapy after involved-field radiotherapy in early-stage follicular lymphoma, including toxicity, relapse and second malignancy data.
    Radiother Oncol. 2026;217:111388.
    >> Share

  6. ATTILI A, Algranati C, Cianchetti M, Giacomelli I, et al
    A dedicated MKM-based radiobiological model for secondary cancer estimation in charged particle radiotherapy: An application in lymphomas and breast proton therapy.
    Radiother Oncol. 2026;214:111229.
    >> Share

    November 2025
  7. LAM EK, Luk MY, Yuen KK, Cheung BM, et al
    Bridging radiotherapy for chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma: Systematic review and meta-analysis.
    Radiother Oncol. 2025;214:111258.
    >> Share

    July 2025
  8. BOERSMA LJ, Hessels A, Roberti S, Seravall E, et al
    Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.
    Radiother Oncol. 2025 Jul 4:110998. doi: 10.1016/j.radonc.2025.110998.
    >> Share

    June 2025
  9. HEIDER S, Allwohn L, Ruhle A, Ehret F, et al
    Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO A
    Radiother Oncol. 2025 Jun 7:110984. doi: 10.1016/j.radonc.2025.110984.
    >> Share

    May 2025
  10. DEDECKOVA K, Andrlik M, Mocikova H, Kaliska L, et al
    Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
    Radiother Oncol. 2025 May 10:110931. doi: 10.1016/j.radonc.2025.110931.
    >> Share

    September 2023
  11. WANG X, Liu X, Zhong QZ, Wu T, et al
    Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
    Radiother Oncol. 2023 Sep 5:109902. doi: 10.1016/j.radonc.2023.109902.
    >> Share

    August 2023
  12. HOFFMANN L, Ehmsen ML, Hansen J, Hansen R, et al
    Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients.
    Radiother Oncol. 2023 Aug 31:109887. doi: 10.1016/j.radonc.2023.109887.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016